Khona Scientific utilizes its proprietary BiDS™ platform to biosynthetically produce complex natural product compounds, transforming simple sugars into bio-identical cannabinoids with high yield and purity. This technology addresses the challenges of traditional extraction methods by providing a consistent, scalable, and cost-effective supply of cannabinoid isolates free from contaminants.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional methods of extracting cannabinoids from plants face challenges related to inconsistent purity, potential contamination from pesticides and heavy metals, and scalability limitations. Biosynthesis of complex compounds like cannabinoids often suffers from low yields, off-pathway production, and high production costs.
Solution
Khona Scientific utilizes its BiDS™ (Biological Design System) platform to biosynthetically produce complex natural product compounds, including bio-identical cannabinoids, by transforming simple sugars into high-purity isolates. The BiDS™ platform optimizes multi-component biological pathways within microbial cells, creating efficient "assembly lines" that minimize off-pathway production, reduce diffusion limits, and mitigate cell toxicity. This approach enables a consistent, scalable, and cost-effective supply of cannabinoid isolates, eliminating the need for remediation steps required in plant-based extraction. The platform's modular design allows for flexible production of various cannabinoids, adapting to market demand.
Target Audience
Khona Scientific serves formulators of nutraceuticals and pharmaceuticals seeking a reliable, high-quality source of bio-identical cannabinoid isolates. The company also targets businesses using rare cannabinoids within their formulations, ensuring supply chain security.
Features
- Patented BiDS™ platform technology for optimized biosynthesis of complex compounds
- Microbial "assembly lines" that convert simple sugars into high-purity cannabinoid isolates
- Production of 20+ unique non-psychoactive cannabinoids, with the ability to add more as pathways are characterized
- High conversion efficiency (85-90%) from sugar to target compound
- cGMP-compliant manufacturing process ensuring regulatory compliance
- Production process free of pesticides, fertilizers, mold, and heavy metals
- Modular design enabling rapid adaptation to new compounds